Physician
Cardiology
Dr. David L. Pearle, MD
|
|
Give Review
David Pearle is an expert in the field of Cardiology. He graduated from Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He over the years received 3 awards: "Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACC)". Doctor David L. Pearle, MD is also a published MD. He has 43 publication published. The most recent publication is: Coronary occlusion site as a determinant of the cardiac rhythm effects of atropine and vagotomy. He accepts Medicare.
Publications
- 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation Myocardial infarction (updating the 2004 guideline and 2007 focused update) a...
- ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Ta...
- ACC/AHA guidelines for the management of patients with ST-elevation Myocardial infarction--executive summary. A report of the American College of Cardiology/American H...
- ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Ta...
- ACC/AHA guidelines for the management of patients with ST-elevation Myocardial infarction--executive summary: a report of the American College of Cardiology/American H...
- Changes in drug prescribing patterns related to commercial company funding of continuing medical education.
- Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe Heart failure. The PRECISE Trial. Prospective Randomized Evalua...
- Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with Chronic heart failure. Principal Investigators of the REFLECT Study.
- Diabetes mellitus and risk of idiopathic dilated Cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study.
- The natural history of Aortic stenosis in adults.
- Aortic dissection masquerading as Acute myocardial infarction: implication for thrombolytic therapy without cardiac catheterization.
- Nifedipine in Acute myocardial infarction.
- Nifedipine therapy for patients with threatened and Acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.
- Nifedipine and conventional therapy for unstable Angina pectoris: a randomized, double-blind comparison.
- Coronary spasm produced by picrotoxin in cats.
- Nonsurgical reperfusion in evolving Myocardial infarction.
- Comparative vagolytic effects of procainamide and N-acetylprocainamide in the dog.
- Effect of digitalis on response of the ventricular pacemaker to sympathetic neural stimulation and to isoproterenol.
- Failure of beta-adrenergic receptor blockade to prevent Arrhythmias induced by sympathetic nerve stimulation.
- Noninvasive detection of Coronary artery patency using continuous ST-segment monitoring.
- Ventricular Arrhythmias during reperfusion.
- Use of hemodynamic measurements for management of Acute myocardial infarction.
- Thrombolysis in Acute myocardial infarction.
- Metabolic support during Coronary reperfusion.
- Calcium antagonists in Acute myocardial infarction.
- Determinants of cardiac failure after coronary bypass surgery within 30 days of Acute myocardial infarction.
- The assessment of contractile reserve after thrombolytic therapy for Acute myocardial infarction.
- Late angiographic follow-up after successful coronary arterial thrombolysis and angioplasty during Acute myocardial infarction.
- Assessment of residual coronary arterial stenosis after thrombolytic therapy during Acute myocardial infarction.
- Ischemia during angioplasty after streptokinase: a marker of Myocardial salvage.
- Beta blockers and calcium channel blocking agents in Acute myocardial infarction.
- Reduction in Coronary heart disease: clinical and anatomical considerations.
- Inhibition of a physiologic pacing system due to its anti-pacemaker-mediated tachycardia mode.
- Liposomal amphotericin B for treatment of Pulmonary aspergillosis in a heart transplant patient.
- Pharmacologic management of ischemic heart Disease with beta-blockers and calcium channel blockers.
- Site of myocardial infarction. A determinant of the cardiovascular changes induced in the cat by Coronary occlusion.
- Coronary occlusion site as a determinant of the cardiac rhythm effects of atropine and vagotomy.
- Role of the nervous system in experimentally induced Arrhythmias.
- Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by Coronary occlusion.
- Clinical experience with nifedipine for Coronary artery spasm.
- Mechanism of cardiovascular changes produced in cats by activation of the central nervous system with picrotoxin.
- 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation Myocardial infarction: a report of the American College of Cardiolo...
Schools
Harvard Medical School
New York Hospital
Georgetown University Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Select
- Amerigroup (Wellpoint)
- KeyCare PPO
- Bakery & Confectionary Union Plan
- Blue Cross Blue Shield
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care of Delaware PPO
- First Health (Coventry Health Care) PPO
- GEHA
- Group Health Cooperative
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- One Net PPO
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACC)
Education
-
Georgetown University Hospital -
New York Presbyterian Hospital - Cornell Campus -
Harvard Medical School
Hospital
-
MedStar Washington Hospital Center -
MedStar Georgetown University Hospital
Drug Facts
| NPI NUMBER | 1275521429 | |
| NPPES Provider LastName | PEARLE | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 200072113 | |
| NPPES Provider State | DC | |
| Specialty Description | Cardiology | |
| Total Claim Count | 692.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275521429 |
| Last Name Of The Provider | PEARLE |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. James B. Strait III, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward D. Belton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean T. Barbey, MD |
|
|
Dr. Jina Sohn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce K. Lloyd III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John E. Francis Jr., MD |
|
|
Dr. Dorinna D. Mendoza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren A. Simprini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bernard Ashby, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Georgia S. Willie-Carnegie, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Newton E. Andrews, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ieon L. Dawson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bernard M. Wagman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas A. Pinder, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph A. Quash Jr., MD |
|
Dr. Rajesh S. Chintala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Smita I. Negi, MD
This Doctor is OpenDoctor Recommended.
|